AdaptHealth (AHCO) Projected to Post Earnings on Tuesday

AdaptHealth (NASDAQ:AHCO) is expected to announce its Q2 2026 results before the market opens on Tuesday, August 4th. Analysts expect AdaptHealth to post earnings of $0.1688 per share and revenue of $846.7740 million for the quarter. Investors are encouraged to explore the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Tuesday, August 4, 2026 at 8:30 AM ET.

AdaptHealth Stock Performance

Shares of AdaptHealth stock opened at $11.17 on Tuesday. The company has a market capitalization of $1.52 billion, a PE ratio of -18.02, a P/E/G ratio of 0.55 and a beta of 1.45. The company has a debt-to-equity ratio of 1.21, a quick ratio of 0.71 and a current ratio of 0.92. The company has a 50-day simple moving average of $10.25 and a two-hundred day simple moving average of $10.67. AdaptHealth has a one year low of $8.51 and a one year high of $13.43.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on AHCO shares. Weiss Ratings reaffirmed a “sell (d)” rating on shares of AdaptHealth in a research report on Friday, May 22nd. Jefferies Financial Group upgraded shares of AdaptHealth from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $11.00 to $13.00 in a research note on Tuesday, July 21st. Truist Financial increased their target price on shares of AdaptHealth from $13.00 to $14.00 and gave the company a “buy” rating in a research report on Monday, April 13th. Royal Bank Of Canada raised their target price on shares of AdaptHealth from $13.00 to $15.00 and gave the company an “outperform” rating in a research note on Monday, May 11th. Finally, UBS Group cut their price target on shares of AdaptHealth from $15.00 to $14.00 and set a “buy” rating on the stock in a report on Wednesday, May 6th. Seven equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $14.14.

Insider Transactions at AdaptHealth

In other AdaptHealth news, insider Russell E. Schuster III sold 11,275 shares of the company’s stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $10.06, for a total transaction of $113,426.50. Following the transaction, the insider owned 136,538 shares in the company, valued at approximately $1,373,572.28. This represents a 7.63% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 1.95% of the company’s stock.

Institutional Trading of AdaptHealth

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. PNC Financial Services Group Inc. lifted its holdings in shares of AdaptHealth by 22.3% during the fourth quarter. PNC Financial Services Group Inc. now owns 7,003 shares of the company’s stock worth $70,000 after purchasing an additional 1,279 shares during the period. Tower Research Capital LLC TRC increased its stake in shares of AdaptHealth by 318.0% in the second quarter. Tower Research Capital LLC TRC now owns 9,592 shares of the company’s stock worth $90,000 after acquiring an additional 7,297 shares during the period. Tidal Investments LLC purchased a new stake in AdaptHealth in the second quarter valued at $96,000. CIBC Bancorp USA Inc. acquired a new stake in AdaptHealth during the 3rd quarter worth about $97,000. Finally, Cerity Partners LLC acquired a new stake in AdaptHealth during the 2nd quarter worth about $104,000. Institutional investors and hedge funds own 82.67% of the company’s stock.

About AdaptHealth

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.